Viacure Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Early Stage VC
- (Cancelled)
- Investors
-
1
Viacure General Information
Description
Developer of diabetes therapies intended to protect and regenerate beta cells. The company develops therapies that block inceptor and replenish insulin stores, enabling the protection of beta cells and the restoration of insulin production.
Contact Information
Website
www.viacure.deCorporate Office
- Südliche Münchner Straße 4
- 82031 Grünwald
- Germany
Corporate Office
- Südliche Münchner Straße 4
- 82031 Grünwald
- Germany
Viacure Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | Cancelled | Startup | ||||
| 2. Seed Round | Completed | Startup | ||||
| 1. Accelerator/Incubator | Completed | Startup |
Viacure Signals
Viacure Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Life Science Factory | Accelerator/Incubator |
Viacure FAQs
-
When was Viacure founded?
Viacure was founded in 2023.
-
Where is Viacure headquartered?
Viacure is headquartered in Grünwald, Germany.
-
What is the size of Viacure?
Viacure has 2 total employees.
-
What industry is Viacure in?
Viacure’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Viacure a private or public company?
Viacure is a Private company.
-
What is Viacure’s current revenue?
The current revenue for Viacure is .
-
Who are Viacure’s investors?
Life Science Factory has invested in Viacure.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process